Lu Juan, Zhu Danhua, Li Lanjuan
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Front Oncol. 2022 Mar 21;12:870983. doi: 10.3389/fonc.2022.870983. eCollection 2022.
In recent years, microRNAs (miRNAs) have attracted much attention because of their prominent role in cancer. An increasing number of studies have shown that miRNAs play an important role in a variety of tumors. miR-608 has been reported to be decreased in cancers, especially in solid tumors. miR-608 is regarded as a tumor suppressor, which has been verified through a large number of experiments both and . miR-608 participates in many biological processes, including cell proliferation, invasion, migration, and apoptosis, by inhibiting transmembrane proteins and many signaling pathways. Here, we summarize the expression profile and biological functions and mechanism of miR-608, suggesting that miR-608 is an ideal diagnostic and prognostic biomarker and a treatment target for cancer.
近年来,微小RNA(miRNA)因其在癌症中发挥的重要作用而备受关注。越来越多的研究表明,miRNA在多种肿瘤中发挥着重要作用。据报道,miR-608在癌症中,尤其是在实体瘤中表达降低。miR-608被视为一种肿瘤抑制因子,这已通过大量体内和体外实验得到证实。miR-608通过抑制跨膜蛋白和许多信号通路参与包括细胞增殖、侵袭、迁移和凋亡在内的许多生物学过程。在此,我们总结了miR-608的表达谱、生物学功能及机制,表明miR-608是一种理想的癌症诊断和预后生物标志物以及治疗靶点。